Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ifosfamide/mesa and encephalopathy.

× No keyword cloud information.

10 in total

Review 1. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors: K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal: Drugs Date: 1991-09 Impact factor: 9.546

Review 2. Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors: T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal: Clin Pharmacokinet Date: 2001-01 Impact factor: 6.447

3. Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma.

Authors: R Pearcey; R Calvert; A Mehta
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

4. Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors.

Authors: M A Gieron; L S Barak; J Estrada
Journal: J Neurooncol Date: 1988 Impact factor: 4.130

5. In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas.

Authors: A H Jäger; U Bogdahn; R Apfel; B Pfeufer; A Dekant
Journal: J Cancer Res Clin Oncol Date: 1993 Impact factor: 4.553

Review 6. Antineoplastic agents. Drug interactions of clinical significance.

Authors: E van Meerten; J Verweij; J H Schellens
Journal: Drug Saf Date: 1995-03 Impact factor: 5.606

Review 7. Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature.

Authors: Karen I Sweiss; Rakesh Beri; Stacy S Shord
Journal: Drug Saf Date: 2008 Impact factor: 5.606

8. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.

Authors: G G Steger; C Dittrich; O Schlappack; R Mader; C Herold; W P Brade; A Keller; K Moser
Journal: J Cancer Res Clin Oncol Date: 1988 Impact factor: 4.553

Review 9. The glycine deportation system and its pharmacological consequences.

Authors: Diren Beyoğlu; Jeffrey R Idle
Journal: Pharmacol Ther Date: 2012-05-11 Impact factor: 12.310

10. A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.

Authors: B M Cantwell; J Carmichael; S Ghani; A L Harris
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

10 in total